Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.705 USD | +0.52% | +4.10% | +48.32% |
04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
03-26 | HC Wainwright Adjusts ADMA Biologics Price Target to $7.50 From $6, Maintains Buy Rating | MT |
- Stock Market
- Equities
- ADMA Stock
- News ADMA Biologics, Inc.